Jeanne P Harvey

Title: Jeanne P. Harvey: Innovator in Cancer Detection

Introduction

Jeanne P. Harvey is a notable inventor based in Pleasanton, CA (US), recognized for her contributions to cancer detection technologies. With a total of 2 patents, her work focuses on diagnostic and prognostic methods that enhance the understanding and detection of malignant tumors.

Latest Patents

Among her latest patents is the "Epidermal Growth Factor Receptor Ectodomain," which provides diagnostic methods for detecting elevated levels of the epidermal growth factor receptor (EGFr) in body fluids, particularly serum. This invention is crucial for identifying mammals with malignant tumor burdens. The patent details the molecular weight range of the EGFr ectodomain, which is between 90 kilodaltons (kd) and 115 kd, with a preferred range of 95 kd to 105 kd, and optimally around 100 kd. Additionally, her "Method of Cancer Detection" patent outlines similar diagnostic methods and includes the development of test kits for performing these assays.

Career Highlights

Jeanne has worked with prominent companies in the diagnostics field, including Chiron Diagnostics Corporation and Ciba Corning Diagnostics Corporation. Her experience in these organizations has significantly contributed to her expertise in medical diagnostics and innovation.

Collaborations

Throughout her career, Jeanne has collaborated with notable professionals such as Roger P. Walker and Patricia A. McDonald, enhancing her research and development efforts in the field of cancer detection.

Conclusion

Jeanne P. Harvey's innovative work in cancer detection through her patents has made a significant impact on the medical diagnostics landscape. Her contributions continue to pave the way for advancements in the detection and treatment of malignant tumors.